Monte Rosa Therapeutics seeks to recruit a highly motivated Analytical Chemistry/Compound Management scientist eager to enable the discovery of molecular glue degraders (MGDs). The successful candidate will be a key contributor responsible for the characterization of novel small-molecule glue-based degraders, enabling Monte Rosa’s growing pipeline. The scientist will independently perform compound purity assays, including proactive and retrospective analyses of internal libraries while supporting associated compound management activities.  

Monte Rosa Therapeutics is searching for a Sr Research Associate - In Vivo on a 6-month contract to assist to in executing pivotal proof-of-concept studies in pre-clinical models in mice of inflammation, immunology, and oncology, and assist in the cross-functional development of our research strategy. The role involves interacting with team members to design and execute in vivo/ex vivo pharmacology studies aimed at defining the activity and mechanism of action of compounds. This person will work primarily in our Animal Care Facility, ideally 11am-7pm, to oversee and perform afternoon/evening and weekend dosing of...

Monte Rosa, an industry leader in targeted protein degradation, is seeking an energetic and self-motivated research associate to join our innovative team working towards discovery of unique molecular glue degraders for the treatment of targeted patient populations in oncology. This is a lab-based position, offering the opportunity to impact oncology projects as they progress from lead optimization to pre-IND studies.   The candidate will be a highly motivated experimentalist with a demonstrated track record of collaboration and a strong desire to contribute to project success.

Monte Rosa Therapeutics (MRT) seeks to recruit an enthusiastic, creative and highly talented medicinal chemist who is eager to discover molecular glue degraders (MGDs) that eliminate disease-causing proteins previously thought undruggable. This position plays a key role in contributing to the development of our growing portfolio and will have a crucial impact at the forefront of drug discovery. The successful candidate should have strong interest in early-stage drug discovery, prior experience in HTS data analysis, hit follow-up as well as utilizing state-of-the-art medicinal chemistry knowledge up to the Lead...

Monte Rosa Therapeutics (MRT) seeks to recruit an experienced, creative and highly talented synthetic and medicinal chemist who is eager to discover molecular glue degraders (MGDs) that eliminate disease-causing proteins that are considered undruggable. The Scientist will play a key role in contributing to the advancement of our growing pipeline portfolio and progressing our drug discovery projects from Lead Identification through development candidate nomination and beyond. The successful candidate should have state-of the-art medicinal chemistry expertise in small molecule drug discovery, prior experience...

Monte Rosa is looking for an experienced Program and Alliance Manager with research and early clinical development experience in biotech to oversee internal and partnered programs. Leveraging their drug development, project management and cross-functional team experience, the successful candidate will manage early-stage internal programs in close collaboration with program leaders, to successfully advance our pipeline. The candidate will be responsible for managing program-related activities, resolving issues, tracking progress of key milestones and budget, and achieving project goals. In addition, this individual will develop and maintain key relationships, both internally and externally, to ensure effective...

Monte Rosa Therapeutics is seeking a highly skilled and self-motivated regulatory professional to join our team as an  Director of Regulatory Affairs. This role will focus on oncology, immunology, and related therapeutic areas. The successful candidate will be responsible for developing and implementing regulatory strategies to support the global development and approval of our innovative therapies.